NetraMark Holdings Inc. (TSX:AIAI)
0.7200
-0.0300 (-4.00%)
At close: Aug 10, 2026
NetraMark Holdings Revenue
NetraMark Holdings had revenue of 10.58K CAD in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 175.85K, down -71.65% year-over-year. In the fiscal year ending September 30, 2025, NetraMark Holdings had annual revenue of 432.50K, down -5.18%.
Revenue (ttm)
175.85K
Revenue Growth
-71.65%
P/S Ratio
403.60
Revenue / Employee
n/a
Employees
n/a
Market Cap
70.97M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 432.50K | -23.63K | -5.18% |
| Sep 30, 2024 | 456.13K | 366.86K | 410.97% |
| Sep 30, 2023 | 89.27K | -23.76K | -21.02% |
| Sep 30, 2022 | 113.03K | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Victory Square Technologies | 55.78M |
| Hydreight Technologies | 55.78M |
| Custom Health Holdings | 25.87M |
| NexgenRx | 18.45M |
| Comprehensive Healthcare Systems | 5.94M |
| Seegnal | 1.84M |
| KDA Group | 419.13K |
| Principal Technologies | 370.42K |
NetraMark Holdings News
- 4 weeks ago - NetraMark Engages AM Public Relations to Support Strategic Communications and Market Awareness - GlobeNewsWire
- 4 weeks ago - NetraMark Signs New Contract To Analyze Phase 2 Neurodegeneration Trial Data With Contract Research Organization Partner - GlobeNewsWire
- 6 weeks ago - NetraMark Signs New NetraAI Clinical Trial Analysis Agreement with Late-Stage Biopharmaceutical Company - GlobeNewsWire
- 2 months ago - NetraMark Announces Presentation at Sidoti Small Cap Conference on June 18, 2026 - GlobeNewsWire
- 2 months ago - NetraMark to Present at the American Society of Clinical Psychopharmacology Annual Meeting - GlobeNewsWire
- 3 months ago - NetraMark Provides Second Quarter Update and Highlights Continued Commercial, Scientific, Regulatory and Capital Markets Momentum - GlobeNewsWire
- 3 months ago - NetraMark Announces Change To Board Of Directors - GlobeNewsWire
- 3 months ago - NetraMark Holdings Inc. (AIAI) Opens the Market - Newsfile Corp